-
Mashup Score: 0Patient Aggression Toward Medical Receptionists Is Common - 9 month(s) ago
Evidence-based measures to improve receptionist working conditions needed, researchers say.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Beyfortus Approved to Prevent RSV Disease in Infants and Toddlers - 9 month(s) ago
Beyfortus is expected to be available for the upcoming 2023-2024 RSV season.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
RSV prevention treatment approved for infants entering their first RSV season. https://t.co/cke6CO6JHB
-
-
Mashup Score: 0Combo Therapy Cuts Relapse Risk in Chronic Inflammatory Demyelinating Polyneuropathy Trial - 9 month(s) ago
The SC formulation of efgartigimod alfa plus hyaluronidase-qvfc is currently marketed under the brand name Vyvgart Hytrulo for generalized myasthenia gravis.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Study shows promising results for drug lower risk of relapse in adults with chronic inflammatory demyelinating polyneuropathy. #CIDP https://t.co/muTzhrRY1C
-
-
Mashup Score: 0MPR Weekly Dose Podcast #165 - 10 month(s) ago
First over-the-counter birth control pill; expanded approval for Leqvio; Gavreto has an indication withdrawn; batches of Albuterol inhalers recalled; results from analysis of paclitaxel-coated devices.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
🎧 New MPR pod out now! 💊 First ever OTC contraceptive; ❤️ Leqvio indication expanded; 🔸 Gavreto indication withdrawn; 🔹 Six batches of Albuterol inhaler recalled; ❤️ Results from anaylsis of paclitaxel-coated devices. https://t.co/xpEhRshAdP
-
-
Mashup Score: 0First Over-the-Counter Birth Control Pill Gets FDA Approval - 10 month(s) ago
Removing the prescription requirement improves access to an effective contraceptive method for women of all ages.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
First ever over-the-counter contraceptive pill approved by FDA. It is expected to be available early next year. https://t.co/PyqAz19v6U
-
-
Mashup Score: 0
The expanded approval now includes patients with comorbidities who have not yet had a first cardiovascular event.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Leqvio approval expanded to include patients with comorbidities who have not yet had a first cardiovascular event. #HeFH #ASCVD https://t.co/xR6ctjU3NA
-
-
Mashup Score: 0Gavreto Indication for RET-Mutant Medullary Thyroid Cancer Withdrawn - 10 month(s) ago
Gavreto is an oral tyrosine kinase inhibitor designed to selectively inhibit RET alterations.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
It was decided that the indication would be withdrawn as the confirmatory trial “could not be activated to fulfill the postmarketing requirement." https://t.co/I0Ao6kB6Id
-
-
Mashup Score: 0Leqembi Granted Traditional Approval for Alzheimer Disease - 10 month(s) ago
Full approval was granted based on efficacy and safety data from the confirmatory phase 3 Clarity AD trial.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
“Today’s action is the first verification that a drug targeting the underlying disease process of Alzheimer disease has shown clinical benefit in this devastating disease.” #AlzheimerDisease #Leqembi https://t.co/sXqLVJflPq
-
-
Mashup Score: 0MPR Weekly Dose Podcast #164 - 10 month(s) ago
New approvals for alopecia, generalized myasthenia gravis and type 1 diabetes; A new osmotic laxative colonoscopy prep; FDA deny approval for a treatment for pre-cirrhotic fibrosis.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
🎧 New MPR Pod out now! 🔹 New approvals for alopecia areata, generalized myasthenia gravis and type 1 diabetes; 🔸 A new low-volume colonoscopy prep; and 🔹 FDA denies approval for a treatment for NASH. https://t.co/aVEB3t9gGs
-
-
Mashup Score: 0Investigational Gonorrhea Vaccine Gets FDA’s Fast Track Designation - 10 month(s) ago
There are currently no vaccines approved for preventing Neisseria gonorrhoeae infection.
Source: MPRCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Gonorrhea vaccine gets Fast Track review. Between 2009 and 2021, the rates of reported gonorrhea increased 118%. #Vaccines https://t.co/ToEZdlfJN4
-
Displays of aggression toward medical receptionists found to be frequent. The study assessed data from US, Australia, Ireland and UK. https://t.co/OUgsgchlpq